Shernan Holtan/LinkedIn
Jan 24, 2025, 17:13
Shernan Holtan: Are we facing a mentorship gap in training the next generation to diagnose and manage chronic GVHD?
Shernan Holtan, Chief of Blood and Marrow Transplantation and Professor of Medicine at Roswell Park Comprehensive Cancer Center, shared a post on LinkedIn:
“Frequently heard from trainees: ‘I only want to do CAR T-cell therapy.’
This may stem from various reasons, including concerns about managing transplant late effects – which are, thankfully, becoming less common and severe as transplant platforms evolve.
Are we facing a mentorship gap in training the next generation to diagnose and manage chronic GVHD? What are your thoughts?
This illustration was generated with the help of OpenAI’s ChatGPT.”
More posts featuring Shernan Holtan.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 24, 2025, 16:24